Analysis

Home > Analysis

Our share price analysis, data and how-to-buy guides cover significant market movements in the most popular UK shares in the FTSE 100, US stocks in the DJIA, commodities, indices, and currency pairs. They are designed to help you make more informed decisions about what to invest in, what to trade, and when to execute currency transactions.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

GlaxoSmithKline
Analysis
Jackson Wong PhD

Why are GlaxoSmithKline (GSK) shares so low? (LON:GSK)

GlaxoSmithKline shares have performed well this year and are up over 15%, but they are still well down from their highs of around 1,800 in 2020 and 2022. In this analysis, I look at why GSK shares are so low, if they will keep on falling and whether or not they are worth a buy

Read More »
Lloyds Share Price Analysis
Analysis
Jackson Wong PhD

Will the Lloyds share price recover above 50p?

Lloyds Banking Group (LLOY) is one of the largest banks in the country. It has 26 million active customers, and post-tax profits last year exceeded £5.5 billion. By most metrics, Lloyds is among the most profitable companies in LSE. In this analysis, I give my thoughts on why the Lloyds share price going down and

Read More »
Vodafone Share Price Analysis
Analysis
Jackson Wong PhD

Will Vodafone shares recover?

Vodafone shares have halved over the last five years. The share price is down over 20% over the last 12 months and down 10% since the start of the year. In this analysis, I look at whether or not the Vodafone share price can recover and if it can get back to its trading channel

Read More »
Tesla (NASD TSLA) share price
Analysis
Jackson Wong PhD

Is it worth buying just one Tesla share? (NASDAQ:TSLA)

They say that one of the best ways to invest is to invest in things that you like. They also say that you make more money investing the sooner you start. So, if you like Tesla and want to start investing, then yes, it is worth buying a single Tesla share. But if you actually

Read More »
Avacta
Analysis
Jackson Wong PhD

Avacta shares are approaching 6 month highs, are they still a buy?

Avacta Life Sciences Group Plc (www.avacta.com) is a small-cap biotech company. Two key divisions support the health company: Oncology drug development (Therapeutics) and Diagnostics. The latter is about expanding the in-vitro diagnostics business to support the medical profession; while the former is about leveraging its proprietary pre|CISION and… To read this article, please register or sign

Read More »
ETF Investing Platforms
Analysis
Darren Sinden

Should you buy the SPDR® FTSE UK All Share UCITS ETF (FTAL)?

The SPDR® FTSE UK All Share UCITS ETF is a market cap weighted tracker that aims to capture the performance of all of the stocks of eligible companies listed on the London Stock Exchange. Encompassing the FTSE 100, 250 and Small cap indices, covering some 98% of the market cap of the UK equity market.

Read More »
Scroll to Top